Home » Topics » BioWorld Science

BioWorld Science
RSS

Pivotal study of budesonide oral suspension in eosinophilic esophagitis achieves endpoints

Oct. 29, 2019

University of Texas System patents CBP and KAT3B inhibitors

Oct. 29, 2019

Phase II results presented for TIMP-GLIA in celiac disease

Oct. 29, 2019

First known case of jaw keratocyst in an individual with SUFU-related Gorlin syndrome

Oct. 29, 2019

Autophagy defects caused by TRAPPC4 variant are associated with syndromic intellectual disability

Oct. 29, 2019

MyoKardia announces promising results from phase IIa study of MYK-491

Oct. 29, 2019

Microbion announces phase Ib data for pravibismane in infected diabetic foot ulcers

Oct. 29, 2019

Interim results presented from pivotal phase III SIERRA study of Iomab-B in AML

Oct. 29, 2019

First subject dosed in phase II ADVISE study of etrasimod in atopic dermatitis

Oct. 29, 2019

Heterozygous p.Leu47Val variant in HSPD1 causes hypomyelinating leukodystrophy

Oct. 29, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...